Artgen Biotech PJSC (MOEX: ISKJ)
Russia
· Delayed Price · Currency is RUB 59.54
+0.84 (1.43%)
At close: Jul 8, 2022
Artgen Biotech PJSC Income Statement
Financials in millions RUB. Fiscal year is January - December.
Millions RUB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 1,493 | 1,369 | 1,137 | 1,181 | 1,084 | 835.58 | Upgrade
|
| Revenue Growth (YoY) | 20.55% | 20.38% | -3.72% | 8.93% | 29.73% | 29.61% | Upgrade
|
| Cost of Revenue | 464.77 | 402.4 | 457.14 | 461.39 | 388.69 | 202.86 | Upgrade
|
| Gross Profit | 1,028 | 966.15 | 679.77 | 719.4 | 695.33 | 632.71 | Upgrade
|
| Selling, General & Admin | 602.72 | 602.72 | 504.82 | 496.52 | 410.94 | 377.28 | Upgrade
|
| Other Operating Expenses | 15.8 | 15.8 | 14.58 | 11.19 | 11.54 | 14.89 | Upgrade
|
| Operating Expenses | 689.41 | 689.41 | 572.88 | 588.98 | 497.37 | 452.19 | Upgrade
|
| Operating Income | 338.38 | 276.74 | 106.89 | 130.42 | 197.97 | 180.52 | Upgrade
|
| Interest Expense | -52.61 | -49.23 | -67.81 | -50.68 | -40.16 | -41.55 | Upgrade
|
| Interest & Investment Income | 65.95 | 32.33 | 12.48 | 6.23 | 3.96 | 4.91 | Upgrade
|
| Earnings From Equity Investments | -17.1 | -24.17 | 23.14 | -5.21 | -0.37 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -1.78 | 2.02 | -3.36 | -1.24 | -0.83 | -1.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -52.73 | -15.44 | -9.1 | -33.11 | -50.83 | -35.25 | Upgrade
|
| EBT Excluding Unusual Items | 280.11 | 222.24 | 62.24 | 46.42 | 109.74 | 107.63 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.4 | -1.4 | - | - | 30.86 | -6.18 | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.34 | -1.34 | -20.63 | -1.69 | 0.92 | - | Upgrade
|
| Asset Writedown | - | - | -5.52 | -9.28 | -45.27 | - | Upgrade
|
| Other Unusual Items | -8.11 | -8.11 | -6.79 | -5.98 | -2.77 | - | Upgrade
|
| Pretax Income | 269.26 | 211.39 | 29.31 | 29.46 | 93.47 | 101.44 | Upgrade
|
| Income Tax Expense | 7.09 | 16.74 | 6.23 | -4.09 | -9.93 | -9.89 | Upgrade
|
| Earnings From Continuing Operations | 262.17 | 194.66 | 23.08 | 33.55 | 103.4 | 111.34 | Upgrade
|
| Minority Interest in Earnings | -42.1 | -25.8 | 23.04 | -21.92 | -30.55 | -26.78 | Upgrade
|
| Net Income | 220.07 | 168.86 | 46.12 | 11.63 | 72.85 | 84.55 | Upgrade
|
| Net Income to Common | 220.07 | 168.86 | 46.12 | 11.63 | 72.85 | 84.55 | Upgrade
|
| Net Income Growth | 315.38% | 266.14% | 296.51% | -84.03% | -13.84% | - | Upgrade
|
| Shares Outstanding (Basic) | 92 | 93 | 87 | 80 | 75 | 75 | Upgrade
|
| Shares Outstanding (Diluted) | 92 | 93 | 87 | 80 | 75 | 75 | Upgrade
|
| Shares Change (YoY) | 0.70% | 6.60% | 8.64% | 6.67% | - | - | Upgrade
|
| EPS (Basic) | 2.39 | 1.82 | 0.53 | 0.15 | 0.97 | 1.13 | Upgrade
|
| EPS (Diluted) | 2.39 | 1.82 | 0.53 | 0.15 | 0.97 | 1.13 | Upgrade
|
| EPS Growth | 312.05% | 243.40% | 264.54% | -85.01% | -13.96% | - | Upgrade
|
| Free Cash Flow | 297.96 | 230.56 | 84.37 | 127.51 | -31.74 | 9.46 | Upgrade
|
| Free Cash Flow Per Share | 3.24 | 2.49 | 0.97 | 1.59 | -0.42 | 0.13 | Upgrade
|
| Dividend Per Share | - | - | 1.000 | - | - | - | Upgrade
|
| Gross Margin | 68.86% | 70.60% | 59.79% | 60.93% | 64.14% | 75.72% | Upgrade
|
| Operating Margin | 22.67% | 20.22% | 9.40% | 11.05% | 18.26% | 21.60% | Upgrade
|
| Profit Margin | 14.74% | 12.34% | 4.06% | 0.99% | 6.72% | 10.12% | Upgrade
|
| Free Cash Flow Margin | 19.96% | 16.85% | 7.42% | 10.80% | -2.93% | 1.13% | Upgrade
|
| EBITDA | 382.98 | 325.9 | 146.93 | 188.79 | 250.84 | 223.78 | Upgrade
|
| EBITDA Margin | 25.66% | 23.81% | 12.92% | 15.99% | 23.14% | 26.78% | Upgrade
|
| D&A For EBITDA | 44.6 | 49.16 | 40.05 | 58.37 | 52.88 | 43.26 | Upgrade
|
| EBIT | 338.38 | 276.74 | 106.89 | 130.42 | 197.97 | 180.52 | Upgrade
|
| EBIT Margin | 22.67% | 20.22% | 9.40% | 11.05% | 18.26% | 21.60% | Upgrade
|
| Effective Tax Rate | 2.63% | 7.92% | 21.26% | - | - | - | Upgrade
|
| Revenue as Reported | 1,493 | 1,369 | 1,137 | 1,181 | 1,084 | 835.58 | Upgrade
|
| Advertising Expenses | - | 106.33 | 72.46 | 61.87 | 43.87 | 38.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.